Details

Autor(en) / Beteiligte

• Peng, Dong-Jie
• Zhang, Yu-Wen
• Li, Zhao-cong
• Li, Shao-Jun
• Cai, Mei
• Qin, Wen-Xia
• Ou, Shi-Yan
• Huang, Xiao-Wei
• Yuan, Zong-Xiang
• Jiang, Yue-Ming

Titel

Preventive impacts of PAS-Na on the slow growth and activated inflammatory responses in Mn-exposed rats

Ist Teil von

• Journal of trace elements in medicine and biology, 2019-07, Vol.54, p.134-141

Ort / Verlag

Germany: Elsevier GmbH

Erscheinungsjahr

2019

Quelle

Access via ScienceDirect (Elsevier)

Beschreibungen/Notizen

• [Display omitted] •Excessive Mn exposure can inhibit the growth and triggered inflammatory responses in Mn-exposed rats.•Preventive treatment with PAS-Na reduce the whole blood Mn concentration of Mn-exposed rats.•Preventive treatment with PAS-Na can improve Mn-exposed rats of retardation and alleviate inflammatory responses. Sodium para-aminosalicylic acid (PAS-Na), an anti-tuberculosis drug, has been demonstrated its function in facilitating the Mn elimination in manganism patients and Mn-exposed models in vivo and improving the symptoms of Mn poisoning. But whether it can improve the growth retardation and inflammatory responses induced by Mn have not been reported. This study was designed to investigate the preventive effects of PAS-Na on the development of retardation and inflammatory responses in Mn-exposed rats. Male Sprague Dawley (SD) rats (8 weeks old, weighing 180 ± 20 g) were randomly divided into normal control group and Mn-exposed group in the 4 weeks experiment observation and normal control group, Mn-exposed group, PAS-Na preventive group and PAS-Na control group in the 8 weeks experiment observation. The Mn-exposed group received an intraperitoneal injection (i.p.) of 15 mg/kg MnCl2 and the normal control group i.p. physiological Saline in the same volume once a day for 4 or 8 weeks, 5 days per week. The PAS-Na preventive group i.p. 15 mg/kg MnCl2 along with back subcutaneous (s.c.) injection of 240 mg/kg PAS-Na once a day for 8 weeks, 5 days per week. PAS-Na control group received s.c. injection of 240 mg/kg PAS-Na along with i.p. injection of saline once daily. The body weight was determined once a week until the end of the experiment. The manganese contents in the blood were detected by graphite furnace atomic absorption spectrometry. The inflammatory factor levels (TNF-α, IL-1β, IL-6, and PGE2) in the blood were detected by using enzyme-linked immunosorbent assay (Elisa) and each organ taking from rats were weighed and recorded. Mn exposure significantly suppressed the growth in rats and increased heart, liver, spleen and kidney coefficients as compared with the control group. The whole blood Mn level and serum levels of IL-1β, IL-6, PGE2, and TNF-α in sub-chronic Mn-exposure group were markedly higher than those in the control group. However, preventive treatment with PAS-Na obviously reduced the whole blood Mn level, the spleen and liver coefficients of the Mn-exposed rats. And serum levels of IL-1β and TNF-α were significantly reduced by 33.9% and 14.7% respectively in PAS-Na prevention group. PAS-Na could improve the growth retardation and alleviate inflammatory responses in Mn-exposed rats.